Art

J-GLOBAL ID：201702229517921676   Reference number：17A0958631

Possible involvement of distinct phylogenetic clusters of HIV-1 variants in the discrepancies between coreceptor tropism predictions based on viral RNA and proviral DNA

ウイルスRNAとプロウイルスDNAに基づくコレセプター向性予測の矛盾へのHIV-1変異の異なる多遺伝子性クラスタの関与の可能性

Author (14)： KOTANI Hiroshi (Keio Univ. Hospital, Tokyo, JPN) ,  KOTANI Hiroshi (Keio Univ. School of Medicine, Tokyo, JPN) ,  SUDO Koji (Keio Univ. School of Medicine, Tokyo, JPN) ,  HASEGAWA Naoki (Keio Univ. School of Medicine, Tokyo, JPN) ,  FUJIWARA Hiroshi (Keio Univ. School of Medicine, Tokyo, JPN) ,  HAYAKAWA Tomohisa (Keio Univ. Hospital, Tokyo, JPN) ,  HAYAKAWA Tomohisa (Keio Univ. School of Medicine, Tokyo, JPN) ,  IKETANI Osamu (Keio Univ. Hospital, Tokyo, JPN) ,  IKETANI Osamu (Keio Univ. School of Medicine, Tokyo, JPN) ,  YAMAGUCHI Masaya (Keio Univ. Hospital, Tokyo, JPN) ,  MOCHIZUKI Mayumi (Keio Univ. Hospital, Tokyo, JPN) ,  MOCHIZUKI Mayumi (Keio Univ., Tokyo, JPN) ,  IWATA Satoshi (Keio Univ. School of Medicine, Tokyo, JPN) ,  KATO Shingo (Keio Univ. School of Medicine, Tokyo, JPN)
Material： Journal of Pharmaceutical Health Care and Sciences (Web)
Volume： 2  Page： 2:31 (WEB ONLY)  Publication year： 2016 
JST Material Number： U1100A  ISSN： 2055-0294  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： *RNA ,...
Semi thesaurus term： *RNA, Viral ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0958631&from=J-GLOBAL&jstjournalNo=U1100A") }}

JST classification (2)： Treatment for infectious diseases,parasitic diseases.  (GD01030D) ,  Physiology and pathogenicity of virus infection  (EG04042Y)

Reference (38)：

• Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol. 1999;17:657-700.
• Panel on Antiretroviral Guidelines for Adults and Adolescents: Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2016. Department of Health and Human Services. Available at http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 7 Nov 2016.
• Vandekerckhove LP, Wensing AM, Kaiser R, Brun-Vézinet F, Clotet B, De Luca A, Dressler S, Garcia F, Geretti AM, Klimkait T, Korn K, Masquelier B, Perno CF, Schapiro JM, Soriano V, Sönnerborg A, Vandamme AM, Verhofstede C, Walter H, Zazzi M, Boucher CA. European Consensus Group on clinical management of tropism testing.: European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis. 2011;11:394-407.
• Saag M, Goodrich J, Fätkenheuer G, Clotet B, Clumeck N, Sullivan J, Westby M, van der Ryst E, Mayer H, A4001029 Study Group. A double-blind, placebo-controlled trial of maraviroc in treatment-experienced patients infected with non-R5 HIV-1. J Infect Dis. 2009;199:1638-47.
• Cooper DA, Heera J, Goodrich J, Tawadrous M, Saag M, Dejesus E, Clumeck N, Walmsley S, Ting N, Coakley E, Reeves JD, Reyes-Teran G, Westby M, Van Der Ryst E, Ive P, Mohapi L, Mingrone H, Horban A, Hackman F, Sullivan J, Mayer H. Maraviroc versus efavirenz, both in combination with zidovudinelamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection. J Infect Dis. 2010;201:803-13.

Terms in the title (10)： ウイルスRNA ,  ウイルスDNA ,  向性 ,  予測 ,  矛盾 ,  HIV-1 ,  変異 ,  遺伝子 ,  クラスタ ,  可能性